Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
CONCLUSIONS: The data suggested that miR-330-3p acted as a tumor gene in HCC by targeting BTG1 and it might be a potential therapeutic target for the HCC treatment.
PMID: 31486488 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Genetics | Hepatocellular Carcinoma | Liver Cancer | Study | Translocation